PAR 2.17% 23.5¢ paradigm biopharmaceuticals limited..

Paradigm patent rejection, page-35

  1. 11 Posts.
    lightbulb Created with Sketch. 7
    The Patent that Hamman is referring to is already issued in relation to PPS and BME. This patent expires in February 2032. The patent rejected in the US is another patent in relation to BME and knee function.

    Detail of the patent issued and patent number can be found in this old announcement

    https://hotcopper.com.au/data/attachments/4147/4147850-ec6e613fbe51d1d788cb5f4e072ada71.jpg
    https://hotcopper.com.au/data/attachments/4147/4147853-0dd473e0ad47af6e38d6070b0f771b00.jpg

 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.5¢
Change
0.005(2.17%)
Mkt cap ! $82.20M
Open High Low Value Volume
23.0¢ 25.0¢ 23.0¢ $211.2K 895.4K

Buyers (Bids)

No. Vol. Price($)
4 82174 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
23.5¢ 49300 8
View Market Depth
Last trade - 16.10pm 06/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.